These findings suggest that stercobilin is involved in obesity/diabetes mellitus through not only proinflammatory activities but also lipid metabolism in the C/EBPβ pathway. The gene discussed is CEBPB; the disease is obesity due to melanocortin 4 receptor deficiency.